Related Experiment Video
Updated: Mar 21, 2026
11:42
Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration
Published on: September 12, 2014
13.0K
[Future Innovative Medicine for Corneal Diseases]
Nippon Ganka Gakkai Zasshi
|May 12, 2016
Summary
This study explores predictive medicine and regenerative therapies for vision preservation in Japan
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Precision Medicine
Context:
- Japan's aging population and declining birth rate necessitate advanced ophthalmological treatments.
- Current treatments focus on chronic conditions like keratoconus, glaucoma, and macular degeneration.
- Next-generation treatments involve predictive medicine and regenerative therapy.
Purpose:
- To investigate predictive markers for conditions like keratoconus.
- To develop regenerative therapies for corneal epithelial and endothelial stem cell deficiencies.
- To explore the role of N-cadherin in corneal epithelial stem cell niches and p75 in corneal endothelial precursor cells.
Summary:
- The study identifies biomarkers and genetic markers to predict keratoconus onset and progression.
- It details the development of autologous oral mucosal cell sheets for corneal epithelial stem cell deficiency.
- Regenerative therapies using iPS cells for corneal epithelium and endothelium are also explored.
Impact:
- Preliminary marker studies aim to predict keratoconus.
- Pioneering regenerative therapies offer new hope for vision restoration.
- The research contributes to developing future ophthalmological treatments for conditions like keratoconus and dry eye.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
01:23Ophthalmic Drug Delivery Systems
208
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
208
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K